№ lp_2_3_36659
Detailed report of breast cancer gene expression tests, their coding, methodology, tissue requirements, and evaluation by HERC for coverage and clinical utility.
Year: 2018
Document Type: Coverage guidance / HTA report
Medical Field: Oncology, Breast Cancer
Procedure Codes: 81518, 81519, 81520, 81521
Test Names: Breast Cancer Index, Oncotype DX, Prosigna, Mammaprint
Methodology: mRNA gene expression profiling, RT-PCR, hybrid capture, microarray
Tissue Type: Formalin-fixed paraffin-embedded, fresh frozen
Algorithms: Recurrence risk score, metastatic recurrence percentage, likelihood of benefit from extended endocrine therapy
Review Body: HERC
Last Review Date: November 2018
Coverage Recommendation: Limited / not covered
Previous Guidance: May 2018
Price: 8 / 10 USD
The file will be delivered to the email address provided at checkout within 12 hours.

Don’t have cryptocurrency yet?

You can still complete your purchase in a few minutes:
  1. Buy Crypto in a trusted app (Coinbase, Kraken, Cash App or any similar service).
  2. In the app, tap Send.
  3. Select network, paste our wallet address.
  4. Send the exact amount shown above.
After sending, paste your TXID (transaction ID) and your email to receive the download link. Need help? Contact support and we’ll guide you step by step.